Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1123 entries
Sorted by: Best Match Show Resources per page
Age-related differences in fibrinolytic parameters in patients with acute traumatic brain injury.

Surgical neurology international

Nakae R, Yokobori S, Takayama Y, Kuwamoto K, Naoe Y, Yokota H.
PMID: 28966820
Surg Neurol Int. 2017 Sep 06;8:214. doi: 10.4103/sni.sni_56_17. eCollection 2017.

BACKGROUND: Coagulopathy and old age have been associated with poor outcomes in traumatic brain injury (TBI) patients; however, the relationships of coagulopathy and age with the acute phase of TBI remain unclear. We hypothesized that coagulation/fibrinolytic abnormalities are more...

Cite
Nakae R, Yokobori S, Takayama Y, et al. Age-related differences in fibrinolytic parameters in patients with acute traumatic brain injury. Surg Neurol Int. 2017;8:214doi: 10.4103/sni.sni_56_17.
Nakae, R., Yokobori, S., Takayama, Y., Kuwamoto, K., Naoe, Y., & Yokota, H. (2017). Age-related differences in fibrinolytic parameters in patients with acute traumatic brain injury. Surgical neurology international, 8214. https://doi.org/10.4103/sni.sni_56_17
Nakae, Ryuta, et al. "Age-related differences in fibrinolytic parameters in patients with acute traumatic brain injury." Surgical neurology international vol. 8 (2017): 214. doi: https://doi.org/10.4103/sni.sni_56_17
Nakae R, Yokobori S, Takayama Y, Kuwamoto K, Naoe Y, Yokota H. Age-related differences in fibrinolytic parameters in patients with acute traumatic brain injury. Surg Neurol Int. 2017 Sep 06;8:214. doi: 10.4103/sni.sni_56_17. eCollection 2017. PMID: 28966820; PMCID: PMC5609444.
Copy Download .nbib Format: NLM
Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data.

World journal of emergency surgery : WJES

Burggraf M, Payas A, Kauther MD, Schoeneberg C, Lendemans S.
PMID: 26396589
World J Emerg Surg. 2015 Sep 22;10:43. doi: 10.1186/s13017-015-0038-1. eCollection 2015.

INTRODUCTION: Traumatic injuries are amongst the leading causes of death worldwide, frequently as a result of uncontrolled hemorrhage. Critical deficiencies in clotting factors have been noted in trauma-induced coagulopathy. However, the exact underlying conditions that result in devastating coagulopathies...

Cite
Burggraf M, Payas A, Kauther MD, et al. Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data. World J Emerg Surg. 2015;10:43doi: 10.1186/s13017-015-0038-1.
Burggraf, M., Payas, A., Kauther, M. D., Schoeneberg, C., & Lendemans, S. (2015). Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data. World journal of emergency surgery : WJES, 1043. https://doi.org/10.1186/s13017-015-0038-1
Burggraf, Manuel, et al. "Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data." World journal of emergency surgery : WJES vol. 10 (2015): 43. doi: https://doi.org/10.1186/s13017-015-0038-1
Burggraf M, Payas A, Kauther MD, Schoeneberg C, Lendemans S. Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data. World J Emerg Surg. 2015 Sep 22;10:43. doi: 10.1186/s13017-015-0038-1. eCollection 2015. PMID: 26396589; PMCID: PMC4578761.
Copy Download .nbib Format: NLM
Cheminformatics-Based Anticoagulant Study of Traditionally Used Medicinal Plants.

Iranian biomedical journal

Alikhani Pour M, Sardari S, Eslamifar A, Azhar A, Rezvani M, Nazari M.
PMID: 28454485
Iran Biomed J. 2017 Nov;21(6):400-5. doi: 10.18869/acadpub.ibj.21.6.400. Epub 2017 Apr 29.

BACKGROUNG: Medicinal plants, as a complementary medicine, have been used to treat various diseases since ancient times. These plants have numerous beneficial applications and are the source of certain conventional drugs. In diseases such as stroke and ischemia, which...

Cite
Alikhani Pour M, Sardari S, Eslamifar A, et al. Cheminformatics-Based Anticoagulant Study of Traditionally Used Medicinal Plants. Iran Biomed J. 2017;21(6):400-5doi: 10.18869/acadpub.ibj.21.6.400.
Alikhani Pour, M., Sardari, S., Eslamifar, A., Azhar, A., Rezvani, M., & Nazari, M. (2017). Cheminformatics-Based Anticoagulant Study of Traditionally Used Medicinal Plants. Iranian biomedical journal, 21(6), 400-5. https://doi.org/10.18869/acadpub.ibj.21.6.400
Alikhani Pour, Mahdi, et al. "Cheminformatics-Based Anticoagulant Study of Traditionally Used Medicinal Plants." Iranian biomedical journal vol. 21,6 (2017): 400-5. doi: https://doi.org/10.18869/acadpub.ibj.21.6.400
Alikhani Pour M, Sardari S, Eslamifar A, Azhar A, Rezvani M, Nazari M. Cheminformatics-Based Anticoagulant Study of Traditionally Used Medicinal Plants. Iran Biomed J. 2017 Nov;21(6):400-5. doi: 10.18869/acadpub.ibj.21.6.400. Epub 2017 Apr 29. PMID: 28454485; PMCID: PMC5572436.
Copy Download .nbib Format: NLM
Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?.

Journal of blood medicine

Korte W.
PMID: 25031548
J Blood Med. 2014 Jul 09;5:107-13. doi: 10.2147/JBM.S35395. eCollection 2014.

Circulating factor XIII (FXIII) consists of two active (A) and two carrier (B) subunits in tetrameric form. Congenital FXIII deficiency is a rare autosomal-recessive trait that mostly results from an FXIII A-subunit deficiency. Classic coagulation assays, such as prothrombin...

Cite
Korte W. Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?. J Blood Med. 2014;5:107-13doi: 10.2147/JBM.S35395.
Korte, W. (2014). Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?. Journal of blood medicine, 5107-13. https://doi.org/10.2147/JBM.S35395
Korte, Wolfgang. "Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?." Journal of blood medicine vol. 5 (2014): 107-13. doi: https://doi.org/10.2147/JBM.S35395
Korte W. Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?. J Blood Med. 2014 Jul 09;5:107-13. doi: 10.2147/JBM.S35395. eCollection 2014. PMID: 25031548; PMCID: PMC4096448.
Copy Download .nbib Format: NLM
Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and ART Status.

Journal of clinical and diagnostic research : JCDR

Thulasi Raman R, Manimaran D, Rachakatla P, Bharathi K, Afroz T, Sagar R.
PMID: 27437222
J Clin Diagn Res. 2016 May;10(5):EC04-6. doi: 10.7860/JCDR/2016/17459.7718. Epub 2016 May 01.

INTRODUCTION: HIV infection is known to cause coagulation abnormalities by various mechanism, especially during its late course.AIM: The objective of this study was to analyse platelet count, prothrombin time and activated partial thromboplastin time among HIV infected patients and...

Cite
Thulasi Raman R, Manimaran D, Rachakatla P, et al. Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and ART Status. J Clin Diagn Res. 2016;10(5):EC04-6doi: 10.7860/JCDR/2016/17459.7718.
Thulasi Raman, R., Manimaran, D., Rachakatla, P., Bharathi, K., Afroz, T., & Sagar, R. (2016). Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and ART Status. Journal of clinical and diagnostic research : JCDR, 10(5), EC04-6. https://doi.org/10.7860/JCDR/2016/17459.7718
Thulasi Raman, R, et al. "Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and ART Status." Journal of clinical and diagnostic research : JCDR vol. 10,5 (2016): EC04-6. doi: https://doi.org/10.7860/JCDR/2016/17459.7718
Thulasi Raman R, Manimaran D, Rachakatla P, Bharathi K, Afroz T, Sagar R. Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and ART Status. J Clin Diagn Res. 2016 May;10(5):EC04-6. doi: 10.7860/JCDR/2016/17459.7718. Epub 2016 May 01. PMID: 27437222; PMCID: PMC4948398.
Copy Download .nbib Format: NLM
The Results of Proximal Femoral Nail for Intertrochanteric Fracture in Hemodialysis Patient.

Hip & pelvis

Song KS, Yoon SP, Lee SK, Lee SH, Yang BS, Park BM, Yang IH, Lee BS, Yeom JU.
PMID: 28316963
Hip Pelvis. 2017 Mar;29(1):54-61. doi: 10.5371/hp.2017.29.1.54. Epub 2017 Mar 06.

PURPOSE: Hip fractures in hemodialysis patients are accompanied by high rates of complications and morbidities. Previous studies have mainly reported on nonunion and avascular necrosis of femoral neck fractures in this patient group. In this study the complication and...

Cite
Song KS, Yoon SP, Lee SK, et al. The Results of Proximal Femoral Nail for Intertrochanteric Fracture in Hemodialysis Patient. Hip Pelvis. 2017;29(1):54-61doi: 10.5371/hp.2017.29.1.54.
Song, K. S., Yoon, S. P., Lee, S. K., Lee, S. H., Yang, B. S., Park, B. M., Yang, I. H., Lee, B. S., & Yeom, J. U. (2017). The Results of Proximal Femoral Nail for Intertrochanteric Fracture in Hemodialysis Patient. Hip & pelvis, 29(1), 54-61. https://doi.org/10.5371/hp.2017.29.1.54
Song, Kyung Sub, et al. "The Results of Proximal Femoral Nail for Intertrochanteric Fracture in Hemodialysis Patient." Hip & pelvis vol. 29,1 (2017): 54-61. doi: https://doi.org/10.5371/hp.2017.29.1.54
Song KS, Yoon SP, Lee SK, Lee SH, Yang BS, Park BM, Yang IH, Lee BS, Yeom JU. The Results of Proximal Femoral Nail for Intertrochanteric Fracture in Hemodialysis Patient. Hip Pelvis. 2017 Mar;29(1):54-61. doi: 10.5371/hp.2017.29.1.54. Epub 2017 Mar 06. PMID: 28316963; PMCID: PMC5352726.
Copy Download .nbib Format: NLM
Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis.

Revista brasileira de hematologia e hemoterapia

De Santis GC, Oliveira LC, Ramos AF, da Silva ND, Falcão RP.
PMID: 25031169
Rev Bras Hematol Hemoter. 2014 Jul-Aug;36(4):290-2. doi: 10.1016/j.bjhh.2014.05.006. Epub 2014 May 28.

Rupture of the spleen can be classified as spontaneous, traumatic, or pathologic. Pathologic rupture has been reported in infectious diseases such as infectious mononucleosis, and hematologic malignancies such as acute and chronic leukemias. Splenomegaly is considered the most relevant...

Cite
De Santis GC, Oliveira LC, Ramos AF, et al. Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis. Rev Bras Hematol Hemoter. 2014;36(4):290-2doi: 10.1016/j.bjhh.2014.05.006.
De Santis, G. C., Oliveira, L. C., Ramos, A. F., da Silva, N. D., & Falcão, R. P. (2014). Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis. Revista brasileira de hematologia e hemoterapia, 36(4), 290-2. https://doi.org/10.1016/j.bjhh.2014.05.006
De Santis, Gil Cunha, et al. "Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis." Revista brasileira de hematologia e hemoterapia vol. 36,4 (2014): 290-2. doi: https://doi.org/10.1016/j.bjhh.2014.05.006
De Santis GC, Oliveira LC, Ramos AF, da Silva ND, Falcão RP. Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis. Rev Bras Hematol Hemoter. 2014 Jul-Aug;36(4):290-2. doi: 10.1016/j.bjhh.2014.05.006. Epub 2014 May 28. PMID: 25031169; PMCID: PMC4207916.
Copy Download .nbib Format: NLM
Acquired factor VIII deficiency: two case reports and a review of literature.

Experimental hematology & oncology

Mo L, Bao GC.
PMID: 28352491
Exp Hematol Oncol. 2017 Mar 24;6:8. doi: 10.1186/s40164-017-0068-3. eCollection 2017.

BACKGROUND: Acquired factor VIII (FVIII) deficiency, or acquired hemophilia A (AHA), is a rare autoimmune disorder involving antibody-mediated depletion of coagulation FVIII, leading to severe, life-threatening bleeding. The condition is often associated with other autoimmune disorders, and its treatment...

Cite
Mo L, Bao GC. Acquired factor VIII deficiency: two case reports and a review of literature. Exp Hematol Oncol. 2017;6:8doi: 10.1186/s40164-017-0068-3.
Mo, L., & Bao, G. C. (2017). Acquired factor VIII deficiency: two case reports and a review of literature. Experimental hematology & oncology, 68. https://doi.org/10.1186/s40164-017-0068-3
Mo, Lan, and Bao, George C. "Acquired factor VIII deficiency: two case reports and a review of literature." Experimental hematology & oncology vol. 6 (2017): 8. doi: https://doi.org/10.1186/s40164-017-0068-3
Mo L, Bao GC. Acquired factor VIII deficiency: two case reports and a review of literature. Exp Hematol Oncol. 2017 Mar 24;6:8. doi: 10.1186/s40164-017-0068-3. eCollection 2017. PMID: 28352491; PMCID: PMC5366150.
Copy Download .nbib Format: NLM
Thrombin generation measured as thrombin-antithrombin complexes predicts clinical outcomes in patients with cirrhosis.

Hepatology research : the official journal of the Japan Society of Hepatology

Kalambokis GN, Oikonomou A, Baltayiannis G, Christou L, Kolaitis NI, Tsianos EV.
PMID: 25847196
Hepatol Res. 2016 Mar;46(3):E36-44. doi: 10.1111/hepr.12520. Epub 2015 May 22.

AIM: Hypercoagulability has been detected in patients with cirrhosis yet its clinical significance remains unclear. We investigated the association of hypercoagulability with clinical outcomes in patients with cirrhosis.METHODS: Thrombin-antithrombin (TAT) complexes as thrombin generation (TG) marker, D-dimer, antithrombin (AT),...

Cite
Kalambokis GN, Oikonomou A, Baltayiannis G, et al. Thrombin generation measured as thrombin-antithrombin complexes predicts clinical outcomes in patients with cirrhosis. Hepatol Res. 2015;46(3):E36-44doi: 10.1111/hepr.12520.
Kalambokis, G. N., Oikonomou, A., Baltayiannis, G., Christou, L., Kolaitis, N. I., & Tsianos, E. V. (2016). Thrombin generation measured as thrombin-antithrombin complexes predicts clinical outcomes in patients with cirrhosis. Hepatology research : the official journal of the Japan Society of Hepatology, 46(3), E36-44. https://doi.org/10.1111/hepr.12520
Kalambokis, Georgios N, et al. "Thrombin generation measured as thrombin-antithrombin complexes predicts clinical outcomes in patients with cirrhosis." Hepatology research : the official journal of the Japan Society of Hepatology vol. 46,3 (2016): E36-44. doi: https://doi.org/10.1111/hepr.12520
Kalambokis GN, Oikonomou A, Baltayiannis G, Christou L, Kolaitis NI, Tsianos EV. Thrombin generation measured as thrombin-antithrombin complexes predicts clinical outcomes in patients with cirrhosis. Hepatol Res. 2016 Mar;46(3):E36-44. doi: 10.1111/hepr.12520. Epub 2015 May 22. PMID: 25847196.
Copy Download .nbib Format: NLM
Prevalence and Resolution of Lupus Anticoagulant in Children.

The Ochsner journal

Kallanagowdar C, Chauhan A, Puertolas MV, Warrier R.
PMID: 27303229
Ochsner J. 2016;16(2):172-5.

BACKGROUND: Lupus anticoagulant (LA) is an autoantibody that inhibits phospholipid-dependent reactions. Studies on the incidence and prevalence of LA in the pediatric population are lacking. The objective of our study was to determine the incidence and potential risk of...

Cite
Kallanagowdar C, Chauhan A, Puertolas MV, et al. Prevalence and Resolution of Lupus Anticoagulant in Children. Ochsner J. 2016;16(2):172-5
Kallanagowdar, C., Chauhan, A., Puertolas, M. V., & Warrier, R. (2016). Prevalence and Resolution of Lupus Anticoagulant in Children. The Ochsner journal, 16(2), 172-5.
Kallanagowdar, Chandra, et al. "Prevalence and Resolution of Lupus Anticoagulant in Children." The Ochsner journal vol. 16,2 (2016): 172-5.
Kallanagowdar C, Chauhan A, Puertolas MV, Warrier R. Prevalence and Resolution of Lupus Anticoagulant in Children. Ochsner J. 2016;16(2):172-5. PMID: 27303229; PMCID: PMC4896663.
Copy Download .nbib Format: NLM
Lupus anticoagulant and anticardiolipin antibodies in SLE with secondary Antiphospholipid Antibody Syndrome.

Turkish journal of haematology : official journal of Turkish Society of Haematology

Garg S, Kurien A.
PMID: 27263620
Turk J Haematol. 2007 Jun 05;24(2):69-74.

Thirty patients with systemic lupus erythematosus (SLE) and suspected secondary antiphospholipid antibody syndrome (APLAS) were evaluated in the study based on their clinical manifestations. The aim was to study the prevalence of various antiphospholipid antibodies, compare the tests used...

Cite
Garg S, Kurien A. Lupus anticoagulant and anticardiolipin antibodies in SLE with secondary Antiphospholipid Antibody Syndrome. Turk J Haematol. 2007;24(2):69-74
Garg, S., & Kurien, A. (2007). Lupus anticoagulant and anticardiolipin antibodies in SLE with secondary Antiphospholipid Antibody Syndrome. Turkish journal of haematology : official journal of Turkish Society of Haematology, 24(2), 69-74.
Garg, Shveta, and Kurien, Annamma. "Lupus anticoagulant and anticardiolipin antibodies in SLE with secondary Antiphospholipid Antibody Syndrome." Turkish journal of haematology : official journal of Turkish Society of Haematology vol. 24,2 (2007): 69-74.
Garg S, Kurien A. Lupus anticoagulant and anticardiolipin antibodies in SLE with secondary Antiphospholipid Antibody Syndrome. Turk J Haematol. 2007 Jun 05;24(2):69-74. PMID: 27263620.
Copy Download .nbib Format: NLM
Plasma levels of thrombin activatable fibrinolysis inhibitor antigen in active and inactive inflammatory bowel disease.

Turkish journal of haematology : official journal of Turkish Society of Haematology

Özcan MA, Akarsu M, Demirkan F, Akpınar H, Yüksel F, Özsan GH, Ündar B, Pişkin Ö, Alacacıoğlu İ.
PMID: 27265290
Turk J Haematol. 2006 Jun 05;23(2):94-9.

BACKGROUND: The clinical course of patients with inflammatory bowel disease (IBD) is frequently complicated by thromboembolic events and may involve the arterial and venous systems. Although not uniformly documented, several studies document substantial alterations in markers of coagulation and...

Cite
Özcan MA, Akarsu M, Demirkan F, et al. Aktif ve aktif olmayan inflamatuar barsak hastalığında trombin ile aktive olan fibrinolizis inhibitör antijeninin plazma düzeyleri. Plasma levels of thrombin activatable fibrinolysis inhibitor antigen in active and inactive inflammatory bowel disease. Turk J Haematol. 2006;23(2):94-9
Özcan, M. A., Akarsu, M., Demirkan, F., Akpınar, H., Yüksel, F., Özsan, G. H., Ündar, B., Pişkin, �. �., & Alacacıoğlu, �. �. (2006). Aktif ve aktif olmayan inflamatuar barsak hastalığında trombin ile aktive olan fibrinolizis inhibitör antijeninin plazma düzeyleri. Plasma levels of thrombin activatable fibrinolysis inhibitor antigen in active and inactive inflammatory bowel disease. Turkish journal of haematology : official journal of Turkish Society of Haematology, 23(2), 94-9.
Özcan, Mehmet Ali, et al. "Aktif ve aktif olmayan inflamatuar barsak hastalığında trombin ile aktive olan fibrinolizis inhibitör antijeninin plazma düzeyleri." Plasma levels of thrombin activatable fibrinolysis inhibitor antigen in active and inactive inflammatory bowel disease. Turkish journal of haematology : official journal of Turkish Society of Haematology vol. 23,2 (2006): 94-9.
Özcan MA, Akarsu M, Demirkan F, Akpınar H, Yüksel F, Özsan GH, Ündar B, Pişkin Ö, Alacacıoğlu İ. Aktif ve aktif olmayan inflamatuar barsak hastalığında trombin ile aktive olan fibrinolizis inhibitör antijeninin plazma düzeyleri. Plasma levels of thrombin activatable fibrinolysis inhibitor antigen in active and inactive inflammatory bowel disease. Turk J Haematol. 2006 Jun 05;23(2):94-9. PMID: 27265290.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1123 entries